Product
Globulina antilinfocitaria
1 clinical trial
6 indications
Indication
Acute Myeloid LeukemiaIndication
Acute Lymphoblastic LeukemiaIndication
Myelodysplastic SyndromesIndication
Chronic Myeloid LeukemiaIndication
MyelofibrosisIndication
Lymphoproliferative DisordersClinical trial
Randomized Study for Comparison of Reduced Intensity Conditioning Protocols Containing Either Thymoglobuline or Alemtuzumab in Patients Undergoing Allogeneic Transplant From Voluntary Unrelated DonorsStatus: Completed, Estimated PCD: 2011-08-01